title: Urine glycoprotein profile reveals novel markers for chronic kidney disease.
abstract: Chronic kidney disease (CKD) is a significant public health problem, and progression to end-stage renal disease leads to dramatic increases in morbidity and mortality. The mechanisms underlying progression of disease are poorly defined, and current noninvasive markers incompletely correlate with disease progression. Therefore, there is a great need for discovering novel markers for CKD. We utilized a glycoproteomic profiling approach to test the hypothesis that the urinary glycoproteome profile from subjects with CKD would be distinct from healthy controls. N-linked glycoproteins were isolated and enriched from the urine of healthy controls and subjects with CKD. This strategy identified several differentially expressed proteins in CKD, including a diverse array of proteins with endopeptidase inhibitor activity, protein binding functions, and acute-phase/immune-stress response activity supporting the proposal that inflammation may play a central role in CKD. Additionally, several of these proteins have been previously linked to kidney disease implicating a mechanistic role in disease pathogenesis. Collectively, our observations suggest that the human urinary glycoproteome may serve as a discovery source for novel mechanism-based biomarkers of CKD.
authors.affiliation: Division of Nephrology, University of Michigan, Ann Arbor, MI 48105, USA.
authors.forename: Anuradha
authors.initials: A
authors.lastname: Vivekanandan-Giri
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Slocum
authors.forename: Carolyn L
authors.initials: CL
authors.lastname: Buller
authors.forename: Venkatesha
authors.initials: V
authors.lastname: Basrur
authors.forename: Wenjun
authors.initials: W
authors.lastname: Ju
authors.forename: Rodica
authors.initials: R
authors.lastname: Pop-Busui
authors.forename: David M
authors.initials: DM
authors.lastname: Lubman
authors.forename: Matthias
authors.initials: M
authors.lastname: Kretzler
authors.forename: Subramaniam
authors.initials: S
authors.lastname: Pennathur
references.citation: Physiol Genomics. 2009 Sep 9;39(1):56-60
references.pmid: 19584173
references.citation: J Am Soc Nephrol. 2008 Jul;19(7):1283-90
references.pmid: 18448586
references.citation: Nat Biotechnol. 2003 Jun;21(6):660-6
references.pmid: 12754519
references.citation: Clin Chem. 2002 Sep;48(9):1445-53
references.pmid: 12194921
references.citation: J Assoc Physicians India. 2005 Jun;53:513-20
references.pmid: 16121805
references.citation: N Engl J Med. 2004 Sep 23;351(13):1296-305
references.pmid: 15385656
references.citation: J Cell Biol. 1998 Jun 1;141(5):1277-86
references.pmid: 9606218
references.citation: Bioinformatics. 2004 Dec 12;20(18):3710-5
references.pmid: 15297299
references.citation: Nat Genet. 2000 May;25(1):25-9
references.pmid: 10802651
references.citation: Am J Kidney Dis. 2003 Oct;42(4):617-22
references.pmid: 14520612
references.citation: FEBS J. 2009 Dec;276(23):7146-58
references.pmid: 19878301
references.citation: Am J Physiol Renal Physiol. 2008 Oct;295(4):F1071-81
references.pmid: 18667486
references.citation: Biol Chem. 2010 Feb-Mar;391(2-3):149-161
references.pmid: 20128687
references.citation: Clin Cancer Res. 2011 May 15;17(10):3349-59
references.pmid: 21459797
references.citation: J Clin Invest. 2007 Mar;117(3):746-56
references.pmid: 17332893
references.citation: JAMA. 2007 Nov 7;298(17):2038-47
references.pmid: 17986697
references.citation: Atherosclerosis. 2011 Jun;216(2):446-51
references.pmid: 21414625
references.citation: Bioinformatics. 2011 Feb 1;27(3):431-2
references.pmid: 21149340
references.citation: Proteomics. 2011 Feb;11(4):805-15
references.pmid: 21229585
references.citation: J Am Soc Nephrol. 2007 Apr;18(4):1057-71
references.pmid: 17329573
references.citation: Am J Nephrol. 2006;26(3):258-67
references.pmid: 16763371
references.citation: Cell. 2001 Mar 23;104(6):809-12
references.pmid: 11290318
references.citation: J Am Soc Nephrol. 2010 Apr;21(4):646-53
references.pmid: 20150539
references.citation: J Am Soc Nephrol. 2011 Mar;22(3):555-70
references.pmid: 21355061
references.citation: FASEB J. 2001 Mar;15(3):559-61
references.pmid: 11259366
references.citation: Diabetes Technol Ther. 2010 Dec;12(12):979-88
references.pmid: 20735160
references.citation: Transplantation. 2010 Mar 15;89(5):548-58
references.pmid: 20134395
references.citation: Kidney Int. 2008 Sep;74(6):799-807
references.pmid: 18596723
references.citation: Mol Cell Proteomics. 2010 Sep;9(9):1954-67
references.pmid: 20501940
references.citation: Kidney Int. 2005 Jun;67(6):2313-20
references.pmid: 15882273
references.citation: J Am Soc Nephrol. 2009 Sep;20(9):2065-74
references.pmid: 19643930
references.citation: J Thorac Cardiovasc Surg. 2010 Mar;139(3):692-700
references.pmid: 20176211
references.citation: Clin Chem. 2004 May;50(5):924-32
references.pmid: 15105350
references.citation: Diabetes Care. 2007 Mar;30(3):629-37
references.pmid: 17327332
references.citation: Proteomics Clin Appl. 2010 Jul;4(6-7):644-53
references.pmid: 21137083
references.citation: Kidney Int. 1998 May;53(5):1209-16
references.pmid: 9573535
references.citation: Hypertension. 2002 Feb;39(2 Pt 2):449-54
references.pmid: 11882588
references.citation: Nephrol Dial Transplant. 2008 Jan;23(1):176-85
references.pmid: 17881425
references.citation: Proteomics. 2005 Jul;5(10):2648-55
references.pmid: 15984045